Predictors of outcome after surgery for gastric cancer in a Western cohort

S Pattison; GB Mann; G Crosthwaite; S Lade; C Mitchell; T Leong; RA Busuttil; A Boussioutas

Journal article

Predictors of outcome after surgery for gastric cancer in a Western cohort

S Pattison, GB Mann, G Crosthwaite, S Lade, C Mitchell, T Leong, RA Busuttil, A Boussioutas

ANZ Journal of Surgery | WILEY | Published : 2016

DOI: 10.1111/ans.12915

Abstract

Background: Gastric cancer (GC) is a common cause of cancer mortality. There are well-documented prognostic factors for GC but these have not been rigorously examined in an Australian context. This study examines the clinical, surgical and histopathological variables associated with survival in a GC cohort from a predominantly Caucasian-based population. Methods: A multi-centre cohort of patients undergoing curative resection for GC enrolled in an ongoing tissue bank study from 1999 to 2009 was retrospectively analysed. Prospectively collected demographic, surgical and pathological variables were available for this cohort. The primary endpoints investigated were cancer-specific survival and ..

View full abstract

University of Melbourne Researchers

Bruce Mann Author

Catherine Mitchell Author

Trevor Leong Author

Alex Boussioutas Author

Related Projects (4)

Gastric cancer: Early detection of disease, relapse and prediction of extent of diasease

Gastric cancer (GC) is the second commonest cause of cancer in the world. The mainstay of treatment for GC is surgical resection, but despit..

SFRP4 AS A NOVEL DIAGNOSTIC AND THERAPEUTIC TARGET FOR GASTRIC CANCER

Gastric cancer is a common cancer with poor survival, but is and potentially curable when diagnosed at an early stage. However currently the..

Molecular markers of the progression of intestinal metaplasia to gastric cancer

Gastric cancer (GC) is the second most common cause of cancer-related death globally. It is a surgically treatable disease that has good pro..

Establishment of a biomarker to test molecular risk of Gastric Cancer

Less than 20% of patients live 5 years after a diagnosis of gastric cancer (GC). This is due to the advanced stage at the time of diagnosis...

Grants

Awarded by National Health and Medical Research Council (NHMRC)

Awarded by Cancer Australia

Awarded by Peter Mac Foundation

Awarded by NHMRC

Funding Acknowledgements

Collection and curation of the study cohort has been funded through a number of grants - National Health and Medical Research Council (NHMRC) project grants (2004-2006 ID288714; 2007-2009 ID454584); 2009-2011 Cancer Australia ID570996; 2012-2014 Peter Mac Foundation grant IDAPP1030980.S. Pattison was supported, in part, by the Odlin Research Fellowship, Royal Australasian College of Physicians and a NHMRC postgraduate scholarship APP1039393.